Detalhe da pesquisa
1.
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study.
Lancet Respir Med
; 6(2): 107-116, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29249325